Home › Procedures › Ultrasound Pelvis › Cigna (eviCore)
📋

Cigna (eviCore) — Ultrasound Pelvis

This page shows prior authorization criteria extracted from Cigna (eviCore)'s published imaging guidelines. 62 matching coverage rules found for this procedure.

Coverage Rules from Cigna (eviCore) Policy

Abdominal Pain

Indication Code: AB-2.2

Abdominal Wall Mass

Indication Code: AB-13.1

Abnormal Uterine Bleeding (AUB)

Indication Code: PV-2.1

Adenomyosis

Indication Code: PV-4.1

Amenorrhea

Indication Code: PEDPV-4.1

Blunt Abdominal Trauma

Indication Code: AB-10.1

Complex Adnexal Masses

Indication Code: PV-5.3

Costello Syndrome

Indication Code: PEDONC-2.14

Endometrial Polyp

Indication Code: PV-12.2

Endometriosis

Indication Code: PV-6.1

Familial Adenomatous Polyposis (FAP) and Related Conditions

Indication Code: PEDONC-2.7

General Guidelines

Indication Code: PV-1.0

General Guidelines

Indication Code: PEDPV-1.0

General Guidelines – Overview

Indication Code: PV-1.1

Hematuria

Indication Code: PEDAB-7

Hematuria

Indication Code: PEDAB-7

Hysteroscopically Placed Tubal Occlusion Device

Indication Code: PV-10.2

Indeterminate Intra-Abdominal Mass

Indication Code: AB-13.2

Inguinal or Femoral Hernia, or Indeterminate Groin Pain

Indication Code: AB-12.1

Initial Infertility Evaluation, Female

Indication Code: PV-9.1

Intrauterine Device

Indication Code: PV-10.1

Left Lower Quadrant Pain

Indication Code: PEDAB-29

Left Lower Quadrant Pain

Indication Code: PEDAB-29

Leiomyoma/Uterine Fibroids

Indication Code: PV-12.1

Li-Fraumeni Syndrome (LFS)

Indication Code: PEDONC-2.2

LUMBAR Syndrome

Indication Code: PEDPVD-5.4

Male Pelvic Disorders

Indication Code: PV-19.1

Melanoma – Surveillance/Follow-up

Indication Code: ONC-5.4

Other Renal Cell Cancer Predisposition Syndromes

Indication Code: PEDONC-2.17

Ovarian Cancer – Suspected/Diagnosis

Indication Code: ONC-21.2

Patent Urachus

Indication Code: PV-23.1

Patent Urachus

Indication Code: PEDPV-15.1

Pediatric Aggressive Mature B-Cell Non-Hodgkin Lymphomas (NHL)

Indication Code: PEDONC-5.3

Pelvic Inflammatory Disease

Indication Code: PV-7.1

Pelvic Pain/Dyspareunia, and Ovarian Torsion

Indication Code: PEDPV-7.1

Pelvic Pain/Dyspareunia, Female

Indication Code: PV-11.1

Pelvic Prolapse

Indication Code: PV-22.3

Penis-Soft Tissue Mass

Indication Code: PV-18.1

Periurethral cysts, Skene duct cyst, Bartholin's gland cysts and Gartner’s duct cyst

Indication Code: PV-13.1

Polycystic Ovary Syndrome

Indication Code: PEDPV-8.1

Polycystic Ovary Syndrome (PCOS)

Indication Code: PV-8.1

Post-Transplant Imaging

Indication Code: PEDONC-20.2

Primary Amenorrhea

Indication Code: PV-3.2

Retained Products of Conception

Indication Code: PV-2.2

Rhabdoid Tumor Predisposition Syndrome

Indication Code: PEDONC-2.11

Screening for Ovarian Cancer

Indication Code: ONC-21.1

Secondary Amenorrhea

Indication Code: PV-3.1

Simple Cysts

Indication Code: PV-5.2

Splenic Trauma

Indication Code: AB-34.2

Suspected Adnexal Mass – Initial Evaluation

Indication Code: PV-5.1

Suspected Physical Child Abuse

Indication Code: PEDMS-7

Suspected Uterine Mass

Indication Code: PV-12.0

Testicular, Ovarian and Extragonadal Germ Cell Tumors – Initial Work-Up/Staging

Indication Code: ONC-20.1

Testicular, Ovarian and Extragonadal Germ Cell Tumors – Restaging/Recurrence

Indication Code: ONC-20.2

Testicular, Ovarian and Extragonadal Germ Cell Tumors – Surveillance

Indication Code: ONC-20.3

Ureteral and/or Bladder Trauma or Injury

Indication Code: PV-25.1

Urethral Diverticula

Indication Code: PV-13.2

Uterine Anomalies

Indication Code: PV-14.1

Uterine Cancer – Initial Work-Up/Staging

Indication Code: ONC-22.2

Uterine Cancer – Suspected/Diagnosis

Indication Code: ONC-22.1

Vaginal Anomalies

Indication Code: PV-14.2

Vaginal Masses

Indication Code: PV-13.3

How to Submit a Prior Authorization Request

Submit via: Cigna Provider Portal (provider.cigna.com) or eviCore at 1-800-252-2021

📄 Required Documentation Checklist

  • Patient demographics and insurance information
  • Ordering provider NPI and contact information
  • Specific clinical indication with ICD-10 diagnosis code(s)
  • Relevant clinical history and physical exam findings
  • Results of prior conservative treatment (if applicable)
  • Prior imaging results relevant to the indication
  • Supporting lab or diagnostic results where applicable

⏱ Turnaround Times

Standard prior authorization requests are typically processed within 3–5 business days. Urgent/expedited requests may be processed within 24–72 hours when clinically necessary.

📣 Appeal Window

Most plans allow 30–60 days to file a first-level appeal. Expedited appeals for urgent cases are typically processed within 72 hours.

⚠ Common Denial Reasons

  • Insufficient clinical documentation to establish medical necessity
  • Clinical criteria not met per payer guidelines
  • Lack of documented prior conservative treatment
  • Missing required prior imaging as step therapy
  • Incorrect or unsupported ICD-10 diagnosis code pairing
  • Request submitted outside of authorization timeframe

Clinical Approval Criteria

✓ Generally Approved When:

  • Document clinical indication: abnormal bleeding, pelvic pain, suspected fibroid/cyst
  • Transvaginal (76830) typically requires documentation that transabdominal was inadequate or clinically insufficient
  • Follow-up for known cysts: document prior ultrasound results and cyst characteristics
← Back to Ultrasound Pelvis overview Search Coverage Database →
Disclaimer: Coverage criteria shown on this page are sourced from publicly available payer guidelines and are provided for informational and educational purposes only. Prior authorization requirements change frequently. Always verify current criteria directly with the payer or their delegated utilization management company before submitting an authorization request. This page does not constitute medical or legal advice.